Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,153 shares of PPH stock, worth $261,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,153
Previous 3,389
6.96%
Holding current value
$261,194
Previous $309,000
10.36%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PPH
# of Institutions
142Shares Held
7.18MCall Options Held
37.7KPut Options Held
471K-
Goldman Sachs Group Inc New York, NY2.76MShares$229 Million0.03% of portfolio
-
Morgan Stanley New York, NY538KShares$44.6 Million0.0% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6512KShares$42.4 Million0.09% of portfolio
-
Wells Fargo & Company San Francisco, CA403KShares$33.4 Million0.01% of portfolio
-
Jane Street Group, LLC New York, NY299KShares$24.8 Million0.01% of portfolio